Patents by Inventor Mark D. Kvarta

Mark D. Kvarta has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of negative modulators of GABA receptors containing alpha5 subunits as fast acting antidepressants
    Patent number: 11083732
    Abstract: Embodiments of the disclosure include methods and compositions related to treatment of one or more medical conditions with one or more negative modulators of GABAA receptors. In specific embodiments, depression and/or suicidability is treated or ameliorated or prevented with one or more negative modulators of GABAA receptors, such as a partial inverse agonist of a GABAA receptor comprising an alpha5 subunit.
    Type: Grant
    Filed: March 31, 2015
    Date of Patent: August 10, 2021
    Assignee: University of Maryland, Baltimore
    Inventors: Scott Thompson, Mark D. Kvarta, Adam Van Dyke
  • USE OF NEGATIVE MODULATORS OF GABA RECEPTORS CONTAINING ALPHA5 SUBUNITS AS FAST ACTING ANTIDEPRESSANTS
    Publication number: 20170020892
    Abstract: Embodiments of the disclosure include methods and compositions related to treatment of one or more medical conditions with one or more negative modulators of GABAA receptors. In specific embodiments, depression and/or suicidability is treated or ameliorated or prevented with one or more negative modulators of GABAA receptors, such as a partial inverse agonist of a GABAA receptor comprising an alpha5 subunit.
    Type: Application
    Filed: March 31, 2015
    Publication date: January 26, 2017
    Applicant: University of Maryland, Baltimore
    Inventors: Scott Thompson, Mark D. Kvarta, Adam Van Dyke